NJ Panel Revokes Coverage For Pharma Co. In Fraud Row

A pharmaceutical company isn't covered for underlying accusations that it was a middleman in a self-dealing scheme orchestrated by its now-deceased board chairman, a New Jersey state appeals court ruled Tuesday,...

Already a subscriber? Click here to view full article